A 48-year-old Spanish journalist with a complex medical history: ALL with Philadelphia chromosome treated with bone marrow transplant (2014), multiple ICU admissions for septic shock, a subdural hematoma after epileptic seizure, and catheter treatment in 2017. She previously tolerated botulinum toxin and fillers without complications.
The procedure demonstrated excellent safety in an oncological patient, with atraumatic technique providing structural support, soft-tissue correction, and natural harmony. The patient experienced an emotional transformation, reporting renewed confidence and well-being.
Neauvia Intense LV (1 ml) using a hybrid, multilayer midface technique with retrograde micro-threads and pre-zygomatic boluses. Neauvia Stimulate (1 ml) delivered subdermally along the preauricular area, jawline, and zygomatic zone to stimulate collagen and correct the mid-fat compartment.
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently based on numerous factors. Outcomes are variable and not guaranteed.